While the pandemic and elections dominated the 2020 news cycle, eight compelling-on-their-own forces quietly came together to form the perfect storm for would-be private equity (PE) acquisition targets. We’ve written a comprehensive piece on the reasons behind this perfect storm, accessible here. See an overview of the eight reasons below:

1. The Already-All-Time Record Level of Investable PE Cash

Back in September 2017, $963B was sitting with PE firms waiting to be invested, and this glut of capital, per Bloomberg, was viewed as a distinct problem:

The size of that pile, and the fact that it keeps rising, is making everyone antsy.

Fast-forward just over two years — at the end of 2019, a record $1.45T sat in private equity funds waiting to be deployed on deals:

What’s 50% more antsy than “antsy”? The same antsy managers are sitting on 50% more capital than they were in 2017, and all their investors are waiting — with different degrees of patience — for them to put that capital to work. 

2. The Coming Deluge of Even More PE Investment Funds

This recent spike in PE fund investment is more the introduction to the real story than the final chapter:

Private equity data provider Preqin estimates that total PE fund assets under management will increase from $10.74T in 2020 to $17.16T in 2025, adding almost as much fresh capital over the next five years as existed in the entire private equity universe just five years ago.

Let’s explore why this market is on the launch pad of such significant growth.

3. Lack of Attractive Investment Options in the Stock Market

Warren Buffett’s favorite valuation metric for the overall U.S. stock market, the Buffett Indicator, is an exceedingly simple measuring stick. You take the value of all the publicly traded companies on U.S. stock markets and divide that number by the U.S. annual gross domestic product (GDP) — the value of all goods and services produced in the U.S. in a year.

If the number is higher than one (U.S. stocks, in aggregate, are worth more than U.S. annual GDP), stocks can be considered expensive. If it’s lower, they can be considered cheap (to the extent they are over or below that 1:1 ratio).

Since the early 1950s, stocks have never been as expensive as they are right now. Put another way, according to the equation that Buffett has said provides “probably the best single measure of where valuations stand at any given moment,” there hasn’t been a worse time to invest in the U.S. stock market in 70 years.

4. Zero-Interest-Rate Policy: The Fixed-Income-Investment Killer

Set by the Federal Reserve, the fed funds rate is the rate at which commercial banks may borrow from the U.S. government. Its current target range, as determined by the Federal Reserve, is 0%-0.25%. A rate range this low is referred to as zero interest rate policy (ZIRP).

When the fed rate is at or near zero, high-quality bonds and other fixed-rate investments are unattractive to investors because they return so little. With returns for high-quality bonds and U.S. Treasuries returning 2.5% and lower per year, this entire, enormous asset class is exceedingly unattractive to investors, PE included.

5. Super Cheap Debt in a Market Where Opportunity Is Largely Defined by Cost to Borrow

The flipside of ZIRP is that while you receive extremely little interest when you lend money out, it costs extremely little in interest to borrow that same money.

So when the cost of borrowed capital from banks to highly qualified, perceived-low-risk professional investment borrowers (PE firms are at or near the top of this list) is near zero, it pays for them to borrow very aggressively, given nearly any ROI at all will result in a profit on funds borrowed at close to 0% interest.

6. Ever-Expanding Acquisition Valuations

Given how fierce competition has become between PE firms when it comes to deal sourcing, it logically follows that valuations have to rise. There are a limited number of companies for which to bid and an ever-increasing pool of funds with which to bid for them. And sure enough, valuations are on the rise:

Note that when the chart says that higher buyout valuations “signal lower returns,” that means for the PE funds paying those higher valuations. If you’re the private company being acquired, this trend signals distinctly higher returns.

7. PE by Any Other Name: The SPAC Attack

There’s a reason that 2020 has been called “The Year of the SPAC” in the private equity world. Also known as blank-check companies, SPACs (special purpose acquisition companies) are unallocated pools of capital that then obtain a publicly traded stock market listing — essentially an IPO without a company — with the intent of acquiring a company for that listing.

So far this year, more than 10x as much money has been allocated to SPACs as in the 10 previous years combined. The rate of SPAC growth is remarkable, and it offers a new avenue for even more investor funds to seek out private companies.

8. Surging Venture Capital Exit Activity

While venture capital and private equity are not synonymous, they are essentially two halves of the same continuum. Venture capital invests in smaller companies, early in their life cycles, that have the potential to become breakout successes. Private equity invests in larger, more mature companies, often immediately following their venture capital-backed startup phase. Yesterday’s venture capital success stories are today’s prime PE targets.

Sure enough, Q3 2020 saw an all-time record for total value of venture capital-backed exits. Competition for startups that have started to gain traction and market share is fierce.

The Bottom Line: No Better Time to Be an Acquisition Target

This is the best seller’s market that there has ever been, and private equity funds are looking — ever more urgently — for the next big thing. Maximizing ROI requires best-in-class branding and a comprehensive, coordinated marketing strategy — positioning your company as its industry’s dynamic, innovative market leader is key to M&A success.

Read the full report for a more in-depth look at the 8 Reasons Why This Is the Best Time Ever to Be an Acquisition Target:

Find out more on SCORR’s M&A capabilities 

About the Author

Roger Boutin, MBA

Vice President of Communications

With 15 years of CRO/drug development experience, Roger is an authority in the drug development industry who knows how to connect strategy and tactics to improve our clients’ ROI. He directs the delivery of content, public relations, and communications, working collaboratively and strategically to help clients reach their goals. Roger has led two rebrands for a top 10, global CRO, giving him a perspective that drives him to deliver innovative, yet practical solutions for our clients’ marketing challenges.